Subgroup analysis showed that LARP4B expression had significant prognostic value in liver cancer patients who were older (P = 0.0049), T3 (P = 0.012), G1/G2 (P = 0.016), male (P = 0.01), and R0 (P = 0.013). Here, LARP4B is linked to liver cancer.